Approval · Notice of Compliance 7539 · 2005
AMARYL: Notice of Compliance 7539
Issued October 7, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7539
- Date
- October 7, 2005
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph: revisions to the dosage and administration section
- Therapeutic class
- Oral hypoglycemic (sulfonylurea)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMARYL | Not yet assigned | — |
Medicinal ingredients
- GLIMEPIRIDE 1 MG per TAB
- GLIMEPIRIDE 2 MG per TAB
- GLIMEPIRIDE 4 MG per TAB